Article Information
PubMed
Published By
History
- Received March 22, 2021
- Revision received August 9, 2021
- Accepted August 17, 2021
- Published online August 20, 2021.
Copyright & Usage
Copyright © 2021 Wołoszynowska-Fraser et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license, which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed.
Author Information
- Marta U. Wołoszynowska-Fraser1,
- Sharyn L. Rossi1,
- Jeffrey M. Long1,
- Peter J. McCaffery2 and
- Peter R. Rapp1
- 1Laboratory of Behavioral Neuroscience, Neurocognitive Aging Section, National Institute on Aging, Baltimore, MD 21224
- 2Institute of Medical Science, School of Medical Sciences, University of Aberdeen, Foresterhill, Aberdeen AB25 2ZD, Scotland, United Kingdom
- Correspondence should be addressed to Peter R. Rapp at rappp{at}mail.nih.gov.
Author contributions
Author contributions: M.U.W.-F., P.J.M., and P.R.R. designed research; M.U.W.-F., S.L.R., and J.M.L. performed research; M.U.W.-F. and J.M.L. analyzed data; M.U.W.-F., S.L.R., J.M.L., P.J.M., and P.R.R. wrote the paper.
Disclosures
P.J.M is non-executive director of Nevrargenics Ltd, a company developing synthetic retinoids for use in neurodegenerative disease. All other authors declare no competing financial interests.
This work was entirely supported by the Intramural Research Program of the National Institutes of Health, National institute on Aging.
Funding
Biotechnology and Biological Sciences Research Council (BBSRC)
BB/P004806/1National Health Service (NHS) Grampian Endowments
16/11/55HHS | NIH | National Institute on Aging (NIA)
ZIA AG000350
Other Version
- You are viewing the most recent version of this article.
- previous version (August 20, 2021).
Online Impact